BioRestorative Therapies
BRTX
11 hedge funds and large institutions have $1.72M invested in BioRestorative Therapies in 2021 Q4 according to their latest regulatory filings, with 11 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
11.37% more ownership
Funds ownership: 0% → 11.37% (+11%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$871K |
| 2 |
BFM
Boothbay Fund Management
New York
|
+$365K |
| 3 |
WA
Wealth Alliance
Mellville,
New York
|
+$228K |
| 4 |
SG
StoneX Group
New York
|
+$85.4K |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
+$57.1K |
Top Sellers
BRTX Hedge Fund Activity: Q4 2021 in Review
11 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in BioRestorative Therapies (BRTX) for Q4 2021, worth a combined $1.72M.
Buyers outnumbered sellers: 11 funds opened new BRTX positions and 0 closed out — a net gain of 11 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Vanguard Group, opening a new position worth an estimated $871K.
- 11 institutional investors held BioRestorative Therapies (BRTX) as of Q4 2021, up from 0 in Q3 2021.
- Funds reported $1.72M of BioRestorative Therapies stock for Q4 2021.
- 11 funds opened new BioRestorative Therapies positions in Q4 2021 and 0 closed out, a net change of +11 holders.
- The largest BioRestorative Therapies buyer in Q4 2021 was Vanguard Group, an estimated $871K added.
Based on aggregated 13F filings for Q4 2021.